Free Trial
→ Federal Reserve Reveals Disturbing New Plan To Control Your Money (From Weiss Ratings) (Ad)tc pixel Free CRVS Stock Alerts

Corvus Pharmaceuticals (CRVS) Short Interest Ratio & Short Volume

Corvus Pharmaceuticals logo
$10.52 +0.31 (+3.04%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$10.52 0.00 (-0.05%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Corvus Pharmaceuticals Short Interest Overview

As of September 30, 2026, Corvus Pharmaceuticals (CRVS) had a short interest of 17.80 million shares sold short, representing 26.35% of the public float. This marks a 3.59% increase in short interest since the prior report. The short interest ratio (days to cover) is 13.3, meaning it would take 13.3 days of the average trading volume of 1.33 million shares to cover all short positions.

Current Short Interest
17,797,751 shares
Previous Short Interest
17,180,341 shares
Change Vs. Previous Month
3.59%
Dollar Volume Sold Short
$205.03 million
Short Interest Ratio
13.3 Days to Cover
Last Record Date
September 30, 2026
Outstanding Shares
84,120,000 shares
Short Percent of Float
26.35%
Today's Trading Volume
1,032,317 shares
Average Trading Volume
1,328,020 shares
Today's Volume Vs. Average
78%
Short Selling Corvus Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CRVS Short Interest Over Time

CRVS Days to Cover Over Time

CRVS Percentage of Float Shorted Over Time

Corvus Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202617,797,751 shares $205.03 million +3.6%26.3%13.31 $11.52
9/15/202617,180,341 shares $222.49 million -9.7%25.4%18.16 $12.95
8/31/202619,017,840 shares $267.01 million -0.6%28.2%29.64 $14.04
8/14/202619,127,098 shares $284.80 million +4.5%28.3%22.53 $14.89
7/31/202618,310,256 shares $242.79 million +1.4%27.1%22.5 $13.26
7/15/202618,061,919 shares $269.48 million -4.0%26.7%12.59 $14.92
6/30/202618,819,891 shares $281.17 million +5.2%27.9%12.38 $14.94
6/15/202617,882,834 shares $212.81 million +3.2%26.5%14.37 $11.90
5/29/202617,324,311 shares $214.99 million -8.4%25.7%8.45 $12.41
5/15/202618,910,283 shares $232.79 million +2.9%28.0%11.98 $12.31
4/30/202618,385,941 shares $279.28 million +8.6%27.2%11.54 $15.19
4/15/202616,928,111 shares $255.78 million -0.1%25.1%21.77 $15.11
3/31/202616,951,894 shares $248.01 million +5.6%25.1%11.09 $14.63
3/13/202616,054,916 shares $245.96 million +0.3%23.8%14.71 $15.32
2/27/202616,009,857 shares $292.34 million +7.6%23.7%13.29 $18.26
2/13/202614,883,150 shares $277.72 million +1.4%22.0%9.81 $18.66
1/30/202614,678,521 shares $303.85 million +27.8%21.7%1.09 $20.70
1/15/202611,486,255 shares $82.01 million -2.8%17.0%7.54 $7.14
12/31/202511,816,663 shares $90.99 million +25.9%17.5%6.47 $7.70
12/15/20259,383,518 shares $78.73 million -4.4%13.9%6.71 $8.39
11/28/20259,812,924 shares $88.51 million -0.9%14.5%12.97 $9.02
11/14/20259,902,822 shares $86.85 million +9.7%19.3%8.72 $8.77
10/31/20259,028,415 shares $72.59 million +2.2%17.6%8.88 $8.04
10/15/20258,830,000 shares $67.90 million -12.6%17.2%12.3 $7.69
9/30/202510,100,000 shares $74.44 million +4.5%N/A16.2 $7.37
9/15/20259,670,000 shares $56.86 million +0.8%N/A13.9 $5.88
8/31/20259,590,000 shares $55.05 million +3.2%18.0%13.1 $5.74
8/15/20259,290,000 shares $50.44 million +5.7%N/A12.7 $5.43
7/31/20258,790,000 shares $36.65 million -2.1%16.5%8.9 $4.17
7/15/20258,980,000 shares $37.45 million +0.9%N/A8.3 $4.17
6/30/20258,900,000 shares $35.60 million +12.1%18.3%7.8 $4.00
6/15/20257,940,000 shares $33.27 million +12.2%16.3%7.4 $4.19
5/31/20257,080,000 shares $26.90 million -2.1%16.0%7.1 $3.80
5/15/20257,230,000 shares $25.88 million +25.3%16.4%7.2 $3.58
4/30/20255,770,000 shares $20.71 million +8.1%N/A6.2 $3.59
4/15/20255,340,000 shares $17.30 million +8.5%12.1%7.8 $3.24
3/31/20254,920,000 shares $15.65 million -8.7%11.1%7.9 $3.18
3/15/20255,390,000 shares $24.36 million +0.8%12.2%6.2 $4.52
2/28/20255,350,000 shares $21.61 million -6.6%12.1%5.8 $4.04
2/15/20255,730,000 shares $27.96 million -6.2%13.0%6.2 $4.88
Iran War Shock: What I Was Told In That Private Meeting (Ad)

You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel

Because THIS is the real reason.
1/31/20256,110,000 shares $32.75 million +11.1%N/A6.2 $5.36
1/15/20255,500,000 shares $27.06 million +1.3%N/A4.9 $4.92
12/31/20245,430,000 shares $29.05 million +26.0%N/A4.7 $5.35
12/15/20244,310,000 shares $31.81 million +22.8%N/A4 $7.38
11/30/20243,510,000 shares $31.91 million +6.4%N/A4.5 $9.09
11/15/20243,300,000 shares $27.03 million +12.6%N/A4.5 $8.19
10/31/20242,930,000 shares $25.90 million +20.1%N/A4.6 $8.84
10/15/20242,440,000 shares $16.40 million +13.5%N/A4.6 $6.72
9/30/20242,150,000 shares $11.35 million +31.1%N/A5.4 $5.28
9/15/20241,640,000 shares $8.36 million +14.7%N/A4.5 $5.10
8/31/20241,430,000 shares $6.41 million +4.4%N/A4.9 $4.48
8/15/20241,370,000 shares $5.21 million +19.1%N/A5.3 $3.80
7/31/20241,150,000 shares $2.96 million -8.0%N/A4.7 $2.57
7/15/20241,250,000 shares $2.50 million -12.6%N/A5.8 $2.00
6/30/20241,430,000 shares $2.60 million -4.7%N/A6.6 $1.82
6/15/20241,500,000 shares $3.06 million -1.3%N/A6.5 $2.04
5/31/20241,520,000 shares $3.28 million +17.8%N/A6.5 $2.16
5/15/20241,290,000 shares $2.86 million -5.2%N/A5.2 $2.22
4/30/20241,360,000 shares $2.11 million -0.7%3.7%5.4 $1.55
4/15/20241,370,000 shares $2.01 million -2.1%3.7%7 $1.47
3/31/20241,400,000 shares $2.49 million -6.0%3.8%6.6 $1.78
3/15/20241,490,000 shares $2.83 million +17.3%4.0%6.8 $1.90
2/29/20241,270,000 shares $2.84 million No Change3.4%5.7 $2.24
2/15/20241,270,000 shares $2.98 million -8.0%3.4%6.2 $2.35
1/31/20241,380,000 shares $2.76 million -1.4%3.7%6.3 $2.00
1/15/20241,400,000 shares $3.28 million +5.3%3.8%6 $2.34
12/31/20231,330,000 shares $2.34 million +2.3%3.6%6.1 $1.76
12/15/20231,300,000 shares $1.99 million -17.2%3.5%6.5 $1.53
11/30/20231,570,000 shares $2.40 million -12.3%4.3%7.9 $1.53
11/15/20231,790,000 shares $2.70 million +4.7%4.9%6.4 $1.51
10/31/20231,710,000 shares $1.93 million -3.4%4.6%6.4 $1.13
10/15/20231,770,000 shares $2.48 million No Change4.8%7.1 $1.40
9/30/20231,770,000 shares $2.58 million -2.8%4.8%6.1 $1.46
9/15/20231,820,000 shares $2.88 million +32.9%4.9%5 $1.58
8/31/20231,370,000 shares $2.90 million +21.2%3.8%2.3 $2.12
8/15/20231,130,000 shares $2.44 million -2.6%3.1%1.8 $2.16
7/31/20231,160,000 shares $2.61 million -17.7%3.4%1.1 $2.25
7/15/20231,410,000 shares $3.47 million +11.9%4.1%1.3 $2.46
6/30/20231,260,000 shares $2.89 million +61.4%3.7%1.1 $2.29
6/15/2023780,600 shares $1.94 million -19.8%2.3%0.7 $2.49
5/31/2023973,100 shares $2.96 million +113.6%2.8%1.1 $3.04
5/15/2023455,500 shares $1.18 million +209.2%1.3%0.6 $2.60
4/30/2023147,300 shares $159.08 thousand -38.3%0.4%0.6 $1.08
4/15/2023238,700 shares $248.25 thousand +50.8%0.7%1.1 $1.04
3/31/2023158,300 shares $144.05 thousand -20.9%0.5%0.8 $0.91
3/15/2023200,200 shares $144.14 thousand +16.9%0.6%2.1 $0.72
2/28/2023171,200 shares $124.98 thousand +35.9%0.5%1.4 $0.73
2/15/2023126,000 shares $97.01 thousand +13.7%0.4%1 $0.77
1/31/2023110,800 shares $90.86 thousand -34.9%0.3%0.8 $0.82
1/15/2023170,100 shares $154.79 thousand -3.7%0.5%1.2 $0.91
Iran War Shock: What I Was Told In That Private Meeting (Ad)

You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel

Because THIS is the real reason.
12/30/2022176,700 shares $150.20 thousand +17.3%0.5%1.2 $0.85
12/15/2022150,600 shares $126.35 thousand -53.8%0.4%1 $0.84
11/30/2022325,900 shares $303.80 thousand +58.1%0.9%2.2 $0.93
11/15/2022206,100 shares $187.96 thousand -0.5%0.6%1.3 $0.91
10/31/2022207,100 shares $179.56 thousand -12.4%0.6%1 $0.87
10/15/2022236,500 shares $215.22 thousand +16.3%0.7%0.9 $0.91
9/30/2022203,300 shares $166.40 thousand +1.6%0.6%0.7 $0.82
9/15/2022200,200 shares $191.19 thousand +70.8%0.6%0.6 $0.96
8/31/2022117,200 shares $112.34 thousand -64.5%0.3%0.4 $0.96
8/15/2022330,500 shares $371.81 thousand -75.2%1.0%1.1 $1.13
7/31/20221,330,000 shares $1.17 million +70.1%3.9%4.7 $0.88
7/15/2022782,000 shares $774.96 thousand -15.2%2.3%3.2 $0.99
6/30/2022922,500 shares $913.37 thousand +306.2%2.7%3.6 $0.99
6/15/2022227,100 shares $224.81 thousand +18.5%0.7%0.9 $0.99
5/31/2022191,600 shares $197.35 thousand -22.9%0.6%0.8 $1.03
5/15/2022248,600 shares $258.54 thousand +28.6%0.7%1 $1.04
4/30/2022193,300 shares $253.22 thousand +5.2%0.6%0.8 $1.31
4/15/2022183,800 shares $266.51 thousand -14.9%0.5%0.7 $1.45
3/31/2022215,900 shares $354.08 thousand +5.2%0.6%0.7 $1.64
3/15/2022205,200 shares $299.59 thousand +3.0%0.6%0.6 $1.46
2/28/2022199,200 shares $352.58 thousand -41.3%0.6%0.5 $1.77
2/15/2022339,300 shares $692.17 thousand +101.5%1.0%0.7 $2.04
1/31/2022168,400 shares $303.12 thousand -43.8%0.5%0.3 $1.80
1/15/2022299,500 shares $673.88 thousand +34.0%N/A0 $2.25
12/31/2021223,500 shares $538.64 thousand -31.2%0.7%0.3 $2.41
12/15/2021324,700 shares $892.93 thousand -43.0%1.0%0.2 $2.75
11/30/2021569,200 shares $1.94 million -45.8%1.9%0.1 $3.41
11/15/20211,050,000 shares $3.89 million -42.9%3.5%0.1 $3.70
10/29/20211,840,000 shares $8.34 million +3.4%6.2%0.2 $4.53
10/15/20211,780,000 shares $8.81 million -42.2%6.3%0.2 $4.95

CRVS Short Interest - Frequently Asked Questions

Short interest is the volume of Corvus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 17,797,751 shares of CRVS short. 26.35% of Corvus Pharmaceuticals' shares are currently sold short. Learn More on Corvus Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRVS shares currently have a short interest ratio of 13.3. Learn More on Corvus Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 26.35% of Corvus Pharmaceuticals' floating shares are currently sold short.

Corvus Pharmaceuticals saw a increase in short interest in September. As of September 30th, there was short interest totaling 17,797,751 shares, an increase of 3.6% from the previous total of 17,180,341 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

26.35% of Corvus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Corvus Pharmaceuticals: Telix Pharmaceuticals Limited (0.13%), Celcuity, Inc. (25.89%), Relay Therapeutics, Inc. (22.46%), Viking Therapeutics, Inc. (21.73%), Veracyte, Inc. (12.87%), Legend Biotech Corporation Sponsored ADR (8.46%), Xenon Pharmaceuticals Inc. (6.44%), ACADIA Pharmaceuticals Inc. (6.51%), Enliven Therapeutics, Inc. (14.57%), IDEAYA Biosciences, Inc. (10.97%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks.

Short selling CRVS is an investing strategy that aims to generate trading profit from Corvus Pharmaceuticals as its price is falling. CRVS shares are trading up $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Corvus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRVS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRVS, twice per month. The most recent reporting period available is September, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CRVS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:CRVS is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month.
From Our Partners
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
The only 5 stocks that matter
SpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...
TradeSmith | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
A simple options setup that cuts through the noise
Ian Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...
TradeWins | Sponsoredtc pixel